ENGN - enGene Holdings Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
8.9 -0.05 (-0.56%)	---	---	---	---	-0.05 (-0.56%)	0.0 (0.0%)	0.0 (0.0%)

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: 0.57
Diluted EPS:: 0.57
Basic P/E:: 15.5263
Diluted P/E:: 15.5263
RSI(14) 1m:: 71.43
VWAP:: 8.81
RVol:: 0.7749

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	8.61 +0.1 (+1.12%)	Oct 15 13:57
1m	Price decrease 1m	8.42 -0.12 (-1.41%)	Oct 15 13:45
1m	Price decrease 1m	8.51 -0.09 (-1.05%)	Oct 15 13:33
1m	Price decrease 1m	8.46 -0.16 (-1.86%)	Oct 15 13:22
1m	Price decrease 1m	8.79 -0.14 (-1.57%)	Oct 15 11:58